Capital Stock Repurchase Plan Transactions

3 Months Ended

Mar. 31, 2020

Capital Stock Repurchase Plan Transactions [Abstract]

Capital Stock Repurchase Plan Transactions

15.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

	Three months ended March 31,
	2020		2019
Total cost of repurchased shares (in thousands)	$	100,235	$	49,250
Shares repurchased		225,000		150,000
Weighted average price per share	$	445.49	$	328.33

In March 2020, the Board of Directors authorized an additional $250.0 million for stock repurchase under Chemed’s existing share repurchase program. We currently have $253.8 million of authorization remaining under this share repurchase plan.